Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: A pilot study

Clinical and Diagnostic Virology

Volumn 8, Issue 1, 1997, Pages 63-70

  Flichman, D ^a   Colombatto, P ^a   Randone, A ^a   Baldi, M ^a   Bellati, G ^b   Negro, F ^a   Oliveri, F ^a   Colucci, G ^c   Verme, G ^a   Bonino, F ^a   Brunetto, M R ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Alpha interferon; Chronic hepatitis C; Hepatitis C virus; Hepatitis C virus RNA; Quantitative polymerase chain reaction

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PILOT PROJECTS; RNA, VIRAL; STATISTICS; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 0031148016     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(97)00013-5     Document Type: Article

References (26)

1. Abate ML, Manzini P, Negro F, Baldi M, Saracco G, Piantino P, Brunetto MR, Bonino F. Detection of hepatitis C virus RNA by reverse-transcriptase and polymerase chain reaction: Clinical applications of quantitative analysis. Clin Diagn Virol 1994;1:289-97.
2. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:697-8.
3. Bonino F, Brunetto MR, Negro F, Baldi M, Saracco G, Abate ML, Fabiano A, Verme G. Hepatitis C virus infection and disease. Diagnostic problems. J Hepatol 1993;17(S3):S78-82.
4. Colloredo Mels G, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, Piantino P, Fornaciari G, Schudeller G, Angeli G, Bonino F, Ideo G. Fluctuations of viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 1994;14:175-81.
5. Douglas DD, Rakela J, Lin HJ, Hollinger FB, Taswell HF, Czaja AJ, Gross JB, Anferson ML, Parent K, Fleming CR, Cangemi JR, O'Brien PC, Powis PE. Randomized controlled trial of recombinant α-2a-interferon for chronic hepatitis C: Comparison of alanine aminotransferase normalization versus loss of HCV-RNA and anti-HCV IgM. Dig Dis Sci 1993;38:601-7.
6. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 1990;336:878-9.
7. Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C antibodies and hepatitis C virus polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C infection in diagnostic virology laboratory. J Clin Microbiol 1992;30:2145-21459.
8. Gretch DR, et al. Detection of hepatitis C virus RNA: Comparison of one-stage polymerase chain reaction (PCR) with nested-set PCR. J Clin Microbiol 1993;31(2):289-91.
9. Gutekunst K, Hardy W, Baniukiewicz A, Wolfe L. A prototype PCR assay for the quantitative detection of HCV-RNA using a single amplification with internal standard. J Hepatol 1994;21(1):S107.
10. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during α interferon therapy. Gastroenterology 1993;104:877-83.
11. Hino K, Sainokami S, Shimoda K, Iiono S, Wang Y, Okamoto H, Miyakawa Y, et al. Genotypes and titers of hepatiis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994;42:299-305.
12. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991;14:381-8.
13. Kaneko S, Murakami S, Unoura M, Kobayashi K. Quantitation of HCV-RNA by competitive polymerase chain reaction. J Med Virol 1992;37:278-82.
14. Lau JY, Davis GL, Kniffen J, Quian KP, Urdea M, Chan C, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis. Lancet 1993a;341:1501-4.
15. Lau JY, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet 1993b;342:1208-9.
16. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995;22(4):1050-6.
17. Negro F, Abate ML, Mondardini A, Baldi M, Leandro G, Lombardi S, Wolfe L, Ryff JC, Verme G, Brunetto MR, Bonino F. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate the hepatitis relapses of patients treated with interferon. J Viral Hep 1995;2:171-4.
18. Pawlotsky J-M, Roundot-Thoraval F, Bastie A, Darthuy F, Remire J, Metreau J-M, Zafrani E-S, Duval J, Dhumeaux D. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J Infect Dis 1996;174:1-7.
19. Rys PN, Pershing DH. Preventing false positives: Quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products. J Clin Microbiol 1993;31:2356-60.
20. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
21. Urdea MS, Horn T, Fultz TJ, Anferson M, Running JA, Hamren S, Ahle D, Chang C. Branch DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. NAR 1991;24:197-200.
22. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo QL, Houghton M. Detection of hepatitis C viral sequences in non-A, non-B hepatitits. Lancet 1990;335:1-3.
23. Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, Tanno M, Urdea MS, Kolberg JA. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 1995;22(5):1351-4.
24. Yoshioka K, Kamuku S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992;16:293-9.
25. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
26. Zaaijer HJ, Cuypers HT, Reesink HW. Reliability of HCV PCR results. Lancet 1993;341:722-4.